The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The clinicopathologic significance of FOXC1 in BRCA-mutant breast cancer.
Michael Phillip Choi
No relevant relationships to disclose
Xiaojiang Cui
No relevant relationships to disclose
Farnaz Dadmanesh
No relevant relationships to disclose
Georgia Liles
No relevant relationships to disclose
Xiao Zhang
No relevant relationships to disclose
Beth Karlan
No relevant relationships to disclose
Armando E. Giuliano
No relevant relationships to disclose
Farin F. Amersi
No relevant relationships to disclose